These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 882587

  • 1. Styrlquinazolones as monoamine oxidase inhibitors.
    Misra RS, Chaudhari A, Chaturvedi AK, Parmar SS, Rama Sastry BV.
    Pharmacol Res Commun; 1977 May; 9(5):437-46. PubMed ID: 882587
    [No Abstract] [Full Text] [Related]

  • 2. Some 2,3,6,8-tetrasubstituted quinazolone hydrazides as monoamine oxidase inhibitors.
    Parmar SS, Arora RC.
    J Med Chem; 1967 Nov; 10(6):1182-3. PubMed ID: 6056057
    [No Abstract] [Full Text] [Related]

  • 3. Correlation between monoamine oxidase inhibitors and anticonvulsants.
    Dwivedi C, Misra RS, Chaudhari A, Parmar SS.
    J Natl Med Assoc; 1980 Oct; 72(10):953-5. PubMed ID: 7420438
    [Abstract] [Full Text] [Related]

  • 4. Anticonvulsant & MAO inhibitory activity of substituted quinazolones.
    Tripathi S, Ahmad S, Barthwal JP, Tangri KK, Kishore K, Bhargava KP.
    Indian J Exp Biol; 1981 Jul; 19(7):630-3. PubMed ID: 7309149
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
    Barthwal JP, Tandon SK, Agarwal VK, Dixit KS, Parmar SS.
    J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982
    [No Abstract] [Full Text] [Related]

  • 6. Substituted quinazolones as potent anticonvulsants and enzyme inhibitors.
    Shrimali M, Kalsi R, Dixit KS, Barthwal JP.
    Arzneimittelforschung; 1991 May; 41(5):514-9. PubMed ID: 1898422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of D-cycloserine with the action of some monoamine oxidase inhibitors.
    Vítek V, Rysánek K.
    Biochem Pharmacol; 1965 Oct; 14(10):1417-24. PubMed ID: 4379549
    [No Abstract] [Full Text] [Related]

  • 12. Monoamine oxidase inhibitory and CNS activities of some quinazolinones.
    Lata A, Satsangi RK, Srivastava VK, Kishor K.
    Arzneimittelforschung; 1982 Oct; 32(1):24-7. PubMed ID: 7199337
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of monoamine oxidase-A activity in rat brain by synthetic hydrazines: structure-activity relationship (SAR).
    Dar A, Khan KM, Ateeq HS, Khan S, Rahat S, Perveen S, Supuran CT.
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):269-74. PubMed ID: 16119198
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of substituted anilino-3-methoxy-4-substituted acetoxy) benzylidenes and their monoamine oxidase inhibitory and anticonvulsant properties.
    Singh SP, Chaudhari A, Stenberg VI, Parmar SS.
    J Pharm Sci; 1976 Nov; 65(11):1678-81. PubMed ID: 994001
    [Abstract] [Full Text] [Related]

  • 16. Studies on monoamine oxidase (report XXIV). Effect of harmine on monoamine oxidase.
    Yasuhara H.
    Jpn J Pharmacol; 1974 Aug; 24(4):523-33. PubMed ID: 4156374
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structure-activity relationships of monoamine oxidase inhibitors.
    Fujita T.
    J Med Chem; 1973 Aug; 16(8):923-30. PubMed ID: 4745836
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.